Gossamer Bio Reports Second-Quarter 2026 Results and Advances Seralutinib Toward Planned FDA Submission Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on developing and potentially commercializing therapies for pulmonary vascular and respiratory diseases, has announced its financial results for the…
Spruce Biosciences Secures $5.5 Million Strategic Investment to Expand Access to Investigational TA-ERT for Children With Sanfilippo Syndrome Type B Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies for neurological disorders with…
Adagio Medical Reports Second-Quarter 2026 Results as Ventricular Tachycardia Program Advances Toward FDA Review Adagio Medical Holdings, Inc., a medical technology company focused on developing innovative catheter ablation solutions for cardiac arrhythmias, has reported its financial results for the second…
Inocras Raises $31 Million to Accelerate U.S. Expansion of Whole-Genome Sequencing Platform for Precision Oncology Inocras Inc., a bioinformatics-driven precision medicine company specializing in whole-genome sequencing (WGS) and advanced genomic analytics, has announced the successful completion of an oversubscribed $31…
N-Zyme Biomedical Secures $4.6 Million Series A Financing to Advance Phase 2 Clinical Programs for Novel Reflux Disease Therapy N-Zyme Biomedical has successfully completed its Series A financing round, raising approximately US$4.6 million to support the continued clinical development of…
Agenus Secures Up to $340 Million in Private Financing to Advance Phase 3 ROBBIN Trial for MSS Colon Cancer Agenus Inc., a biotechnology company focused on developing innovative immuno-oncology therapies, has announced that it has entered into a securities purchase…
AdvanCell Raises US$315 Million in Oversubscribed Series D Financing to Advance Lead-212 Targeted Alpha Therapy Platform AdvanCell, a clinical-stage radiopharmaceutical company focused on developing targeted alpha therapies for cancer, has announced the successful completion of an oversubscribed and expanded US$315…
Anodyne Nanotech Raises $12.6 Million Series A to Advance Weekly GLP-1 Patch for Obesity and Expand Transdermal Drug Delivery Platform Anodyne Nanotech Inc., a clinical-stage biotechnology company focused on transforming chronic disease treatment through transdermal drug delivery, has announced the…
Biocom Report Highlights California Life Science Industry’s $394 Billion Economic Impact and Resilience in 2025 Biocom, the largest life science membership association representing companies across California and other major life science markets, has released its 2026 Life Science Economic Impact…
BioTalent Canada Launches BioInsights to Deliver Labour Market Intelligence for Canada’s Bio-Economy BioTalent Canada has unveiled BioInsights, a new labour market intelligence consulting service designed to support organizations operating across Canada’s growing bio-economy. The new offering is intended to provide…
WISE Raises €30 Million in Oversubscribed Series D Round to Advance Heron Spinal Cord Stimulation Lead and Expand Neurotechnology Platform WISE S.p.A., an Italian medical device company developing advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interface applications, has completed…
bioAffinity Technologies Closes $3.2 Million Public Offering to Support Growth in Lung Disease Diagnostics bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic tools for the early detection of lung cancer and other pulmonary diseases, has completed a…